Isolation and characterization of new 18-membered macrolides FD-891 and FD-892

Area of Science:

• Microbiology
• Natural Products Chemistry
• Pharmacology

Background:

• Streptomyces species are a prolific source of bioactive natural products.
• Macrolides represent a significant class of antibiotics and anticancer agents.
• The search for novel anticancer compounds remains a critical area of research.

Purpose of the Study:

• To discover and characterize new macrolide compounds from Streptomyces graminofaciens.
• To evaluate the cytotoxic activity of these novel macrolides against in vitro tumor cell lines.
• To compare the efficacy of the novel compounds with a known chemotherapeutic agent, doxorubicin.

Main Methods:

• Isolation and purification of macrolides from Streptomyces graminofaciens A-8890 fermentation broth.
• Determination of chemical structures of the isolated compounds.
• Assessment of morphological changes in HL-60 cells induced by the compounds.
• In vitro evaluation of cytocidal activity against various tumor cell lines.

Main Results:

• Two new 18-membered macrolides, FD-891 and FD-892, were identified.
• Both compounds induced morphological changes in HL-60 cells at sub-IC50 concentrations.
• FD-891 demonstrated significant cytocidal activity against in vitro tumor cell lines, showing 2-7 times greater potency than doxorubicin.
• FD-892 exhibited weaker activity compared to FD-891 and doxorubicin.

Conclusions:

• Streptomyces graminofaciens A-8890 produces novel macrolides with potential anticancer properties.
• FD-891 is a promising candidate for further investigation as an anticancer agent due to its superior activity compared to doxorubicin.
• FD-892 may serve as a valuable tool for structure-activity relationship studies in macrolide research.